Heparin is a sulphur containing
polysaccharide, used as an anticoagulant in the treatment of thrombosis.
Heparin is an injectable blood thinner that primarily prevents the formation of
blood clots and is produced in the body by basophils and mast cells. Moreover,
it is used to prevent and treat deep vein thrombosis and pulmonary embolism,
myocardial infarction and unstable angina. Heparin is usually stored within the
secretory granules of mast cells and released only into the vasculature at
sites of tissue injury. The global heparin market witnessed lucrative growth
over the past few years owing to rising heart diseases and rapid lifestyle
changes around the world.

The global heparin market was
valued at USD 8.99 billion in 2016 and it is projected to grow at a CAGR of
5.91% over the forecast period to reach to USD 13.44 billion in 2023.

Globally, the heparin
market is growing steadily due to increasing incidences of coagulation
disorders, substantial growth in the number of the people suffering from
diseases like venous thromboembolism (VTE), deep vein thrombosis and heart
diseases. In addition, the considerable rise in the prevalence of the obesity
is also expected to support the global growth of this market. However,
stringent regulatory framework across different regions and side effects of the
porcine heparin are likely to limit the global growth of heparin market. A
heparin market is expected to experience adoption of synthetic heparin by
leading players in the industry. With adoption of synthetic heparin, the global
market is anticipated to augment the opportunities for the leading market
player in the industry over the forecast period. Furthermore, Technological
advancement and rising demand for heparin also expected to escalate growth in
this market over the forecast period.

The report provides
regional analysis covering geographies such as North America, Europe,
Asia-Pacific, and Rest of the World. Asia pacific, North America and ROW are
considered to be the prominent markets for heparin, whereas Asia pacific is
expected to be the largest geographic segment growing at a CAGR from of XX%
over the forecast period.

Figure: Global Heparin Market Geographic Coverage and
Analysis

On the other hand,
North America dominated the global market and registered as the highest revenue
generating region in 2014. The growth heparin market in North America region is
attributed to the sophisticated healthcare infrastructure; increasing number of
medical tourists and large number of surgical procedures conducted in the
country.

Companies Profiled:

The companies covered
in the report include

Sanofi SA

GlaxoSmithKline plc

Pfizer, Inc.

Leo Pharma

Dr. Reddy’s
Laboratories

Fresenius SE &
Co. KG

Teva Pharmaceutical
Industries Ltd.

Baxter International

Aspen Holdings

Report Highlights:

The report provides
deep insights on demand forecasts, market trends and micro and macro
indicators. In addition, this report provides insights on the factors that are
driving and restraining the demand of heparin globally as well as regionally.
Moreover, IGR-Growth Matrix analysis given in the report brings an insight on
the investment areas that existing or new market players can consider.

The report provides
insights into the market using analytical tools such as Porter’s five forces
analysis and value chain analysis of heparin market. Moreover, the study
highlights current market trends and provides forecast from 2017 to 2023. We
also have highlighted future trends in heparin market that will impact the
demand during the forecast period. Moreover, the competitive analysis given in
each regional market brings an insight on the market share of the leading
players. Additionally, the analysis highlights rise and fall in the market
shares of the key players in the market.

The report also
provides in depth analysis of regulatory framework pertaining to Heparin
Market. This will help the companies to understand the regulatory compliances,
supports, barriers in the Heparin market.
This section highlights key amendments and their implication on Heparin
market in the short run as well as in the long run. This report will help
manufacturers, suppliers and distributors of the heparin market to understand
the present and future trends in this market and formulate their strategies
accordingly.

The Infinium Advantages

Analyst Support

Get free analyst support for the queries before and post purchasing report.

Customer Satisfaction

Be assured of 100% customer satisfaction about the research and get 24X7 customer support.

400% Growth

Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.